The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia
- PMID: 192874
- DOI: 10.1016/s0022-3476(77)80560-x
The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia
Abstract
The response of plasma progesterone, 17 alpha-hydroxyprogesterone (17-OHP), and cortisol to intravenous ACTH was determined in 16 control subjects and seven sets of parents of children with congenital virilizing adrenal hyperplasia. The baseline and poststimulation concentrations of hormones (of each group) were similar except for those of 17-OHP in the parents which were significantly greater following administration of ACTH. When rates of increase were determined, those of progesterone and 17-OHP but not cortisol were significantly greater in the parents. The combined rate of increase of progesterone and 17-OHP was calculated; 10 of the 14 parents had a combined rate of increase greater than the mean plus two standard deviations of the control group. This test provides a simple method for the detection of some heterozygous carriers for CVAH.
Similar articles
-
An attenuated form of congenital virilizing adrenal hyperplasia.J Clin Endocrinol Metab. 1979 Sep;49(3):335-9. doi: 10.1210/jcem-49-3-335. J Clin Endocrinol Metab. 1979. PMID: 224072
-
Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17-OH progesterone.J Pediatr. 1977 Jun;90(6):930-3. doi: 10.1016/s0022-3476(77)80561-1. J Pediatr. 1977. PMID: 859065
-
Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.J Clin Invest. 1969 May;48(5):930-9. doi: 10.1172/JCI106052. J Clin Invest. 1969. PMID: 4305376 Free PMC article.
-
Detection of the heterozygous state in siblings of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.J Pediatr. 1979 May;94(5):770-2. doi: 10.1016/s0022-3476(79)80152-3. J Pediatr. 1979. PMID: 221633 No abstract available.
-
Evidence for partial 21-hydroxylase deficiency among heterozygote carriers of congenital adrenal hyperplasia.J Clin Endocrinol Metab. 1975 Aug;41(2):415-8. doi: 10.1210/jcem-41-2-415. J Clin Endocrinol Metab. 1975. PMID: 169282
Cited by
-
HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.J Endocrinol Invest. 1992 Jun;15(6):429-36. doi: 10.1007/BF03348766. J Endocrinol Invest. 1992. PMID: 1328348
-
New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.J Endocrinol Invest. 1995 Nov;18(10):754-61. doi: 10.1007/BF03349807. J Endocrinol Invest. 1995. PMID: 8787951
-
17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.J Endocrinol Invest. 1996 Dec;19(11):745-52. doi: 10.1007/BF03347878. J Endocrinol Invest. 1996. PMID: 9061508
-
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.J Endocrinol Invest. 1979 Jan-Mar;2(1):93-100. doi: 10.1007/BF03349283. J Endocrinol Invest. 1979. PMID: 385704 Review. No abstract available.
-
17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in CYP21A2 Heterozygous Carriers and Non-carriers in Symptomatic and Asymptomatic Groups: Meta-analyses.J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):56-68. doi: 10.4274/jcrpe.galenos.2021.2021.0184. Epub 2021 Nov 8. J Clin Res Pediatr Endocrinol. 2022. PMID: 34743977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical